Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02292498 · ClinicalTrials.gov registry record · NA

Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT02292498: Completed NA study, sponsored by Massachusetts General Hospital.

NCT02292498 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02292498, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The purpose of this study is to test the feasibility of using thermal images to diagnose bacterial pneumonia instead of a chest x-ray in the future. More specifically, the objectives of this study are: 1) to determine if thermal imaging, using a commercial thermal camera can detect areas of heat emitted from the chest in similar locations to where a chest X-ray shows focal consolidation consistent with bacterial pneumonia; 2) to evaluate whether changes in heat emitted from the chest changes over time if it is possible to obtain serial images of the chest.

Primary Outcome

Thermal imaging will be compared to the chest x-ray taken within 4 hours to see if bacterial pneumonia is present

Interventions

  • DEVICE FLIR ONE

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2014-11
Est. Completion 2016-06
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02292498 record still lists

NCT02292498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which FLIR ONE is the first listed.

NCT02292498 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02292498 about?

NCT02292498 is a clinical study titled "Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections". The purpose of this study is to test the feasibility of using thermal images to diagnose bacterial pneumonia instead of a chest x-ray in the future. More specifically, the objectives of this study are: 1) to determine if thermal imaging, using a commercial thermal camera can detect areas of heat emi...

What is the current status of trial NCT02292498?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-11. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02292498?

The interventions under investigation include: FLIR ONE (DEVICE).

Who is sponsoring clinical trial NCT02292498?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02292498's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02292498, the US trial registry maintained by the National Library of Medicine. NCT02292498 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.